You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Ceftizoxime sodium - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for ceftizoxime sodium and what is the scope of freedom to operate?

Ceftizoxime sodium is the generic ingredient in three branded drugs marketed by Astellas and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for ceftizoxime sodium.

Summary for ceftizoxime sodium
Recent Clinical Trials for ceftizoxime sodium

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Alphacait, LLCPhase 2
Federal University of São PauloPhase 4

See all ceftizoxime sodium clinical trials

Medical Subject Heading (MeSH) Categories for ceftizoxime sodium

US Patents and Regulatory Information for ceftizoxime sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CEFIZOX IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-003 Apr 13, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-002 Oct 3, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX ceftizoxime sodium INJECTABLE;INJECTION 050560-002 Sep 15, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX ceftizoxime sodium INJECTABLE;INJECTION 050560-001 Sep 15, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-001 Oct 3, 1984 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astellas CEFIZOX ceftizoxime sodium INJECTABLE;INJECTION 063294-003 Mar 31, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.